Health Affairs, 28, no. 5 (2009): 1556
doi: 10.1377/hlthaff.28.5.1556
© 2009 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Extract Freely available
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Google Scholar
* Articles by Russell, L.
PubMed
* PubMed Citation
* Articles by Russell, L.

Letters

Prevention: Russell Responds


As the title of my Jan/Feb 09 article implies, and the article and abstract explain, a minority of preventive interventions do reduce medical spending. So do a minority of treatments. There might be more if prices were lower. A recent analysis reported that statins would be cost-saving at less than 10 cents per pill.1 Nonetheless, over the full range of effective prevention, four decades of studies show that most preventive interventions add more to medical spending than they save.

Aspirin, pediatric immunizations, and smoking cessation are certainly among the most cost-effective interventions, but more-nuanced conclusions are needed. As I noted in my article, aspirin is cost-saving for men at high risk of heart disease but might not even be beneficial for women.2 Screening for tobacco use improves health only if it leads to smoking cessation. A study funded by the Agency for Healthcare Research and Quality (AHRQ) found that smoking cessation programs add a few thousand dollars to medical spending for each year of life they save—excellent value, but not cost-saving.3

I agree with Thomas Kottke and his colleagues that it is important to identify those preventive interventions, and treatments, that contribute the most to better health. If we did a better job of setting these priorities, Americans might enjoy the longer lifespans of citizens in other high-income countries, all of which spend less than we do on medical care.

Louise Russell
Rutgers University, New Brunswick, New Jersey

  NOTES
 

  1. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rondoni N, Coxson P, et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009;150(4):243–54.[Abstract/Free Full Text]
  2. Pignone M, Earnshaw S, Pletcher MJ, Tice JA. Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis. Arch Intern Med. 2007;167(3):290–5.[Abstract/Free Full Text]
  3. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA. 1997;278(21): 1759–66.[Abstract/Free Full Text]


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?